Biomedical Engineering Reference
In-Depth Information
[56]
Perkins AC (1998). Enrichment of blood from embryonic stem cells
in vitro
. Reproduction,
Fertility and Development 10: 563-572.
[57]
Gunsilius E, G Gastl and A Petzer (2001). Hematopoietic stem cells. Biomedicine and pharma-
cotherapy 55: 186-194.
[58]
Weissman I (2000). Stem cells: units of development, units of regeneration, and units in evolu-
tion. Cell 100: 157-168.
[59]
Cohnheim J (1867). Ueber entzündung und eiterung. Virchows Archiv 40: 1-79.
[60]
Prockop DJ (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science
276: 71-74.
[61]
Friedenstein AJ, J Gorskaja and N Kulagina (1976). Fibroblast precursors in normal and irra-
diated mouse hematopoietic organs. Experimental Hematology 4: 267-274.
[62]
Lindroos B, R Suuronen and S Miettinen (2011). The potential of adipose stem cells in regener-
ative medicine. Stem Cell Reviews and Reports 7: 269-291.
[63]
Fraser JK, I Wulur, Z Alfonso and MH Hedrick (2006). Fat tissue: an underappreciated source
of stem cells for biotechnology. Trends in Biotechnology 24: 150-154.
[64]
Boquest AC, A Shahdadfar, JE Brinchmann and P Collas (2006). Isolation of stromal stem cells
from human adipose tissue. In Nuclear Reprogramming: Methods and Protocols, S. Pells (ed.).
Springer: Berlin; 35-46.
[65]
McIntosh K, S Zvonic, S Garrett, JB Mitchell, ZE Floyd, L Hammill, A Kloster, Y Di Halvorsen,
JP Ting and RW Storms (2006). The immunogenicity of human adipose-derived cells: temporal
changes
in vitro
. Stem Cells 24: 1246-1253.
[66]
Kucerova L, V Altanerova, M Matuskova, S Tyciakova and C Altaner (2007). Adipose tissue-
derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Research
67: 6304-6313.
[67]
Zhu W, W Xu, R Jiang, H Qian, M Chen, J Hu, W Cao, C Han and Y Chen (2006). Mesenchymal
stem cells derived from bone marrow favor tumor cell growth
in vivo
. Experimental and
Molecular Pathology 80: 267-274.
[68]
Cousin B, E Ravet, S Poglio, F De Toni, M Bertuzzi, H Lulka, I Touil, M André, J-L Grolleau
and J-M Péron (2009). Adult stromal cells derived from human adipose tissue provoke pancreatic
cancer cell death both
in vitro
and in vivo. PLoS One 4: e6278.
[69]
Chamberlain G, J Fox, B Ashton and J Middleton (2007). Concise review: mesenchymal stem
cells: their phenotype, differentiation capacity, immunological features, and potential for homing.
Stem cells 25: 2739-2749.
[70]
Haynesworth S, M Barer and A Caplan (1992). Cell surface antigens on human marrow-derived
mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80.
[71]
Uccelli A, L Moretta and V Pistoia (2006). Immunoregulatory function of mesenchymal stem
cells. European Journal of Immunology 36: 2566-2573.
[72]
Rasmusson I (2006). Immune modulation by mesenchymal stem cells. Experimental cell research
312: 2169-2179.
[73]
Nauta AJ and WE Fibbe (2007). Immunomodulatory properties of mesenchymal stromal cells.
Blood 110: 3499-3506.
[74]
Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and
AM Gianni (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation
induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
[75]
Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine,
D Ucker and R Deans (2002). Mesenchymal stem cells suppress lymphocyte proliferation
in
vitro
and prolong skin graft survival in vivo. Experimental Hematology 30: 42-48.
[76]
Soleymaninejadian E, K Pramanik and E Samadian (2012). Immunomodulatory properties of
mesenchymal stem cells: cytokines and factors. American Journal of Reproductive Immunology
67: 1-8.
[77]
Jorgensen C (2010). Mesenchymal stem cells immunosuppressive properties: is it specific to bone
marrow-derived cells? Stem Cell Research and Therapy 1: 15.
[78]
Rutella S, S Danese and G Leone (2006). Tolerogenic dendritic cells: cytokine modulation comes
of age. Blood 108: 1435-1440.
